NAII

Natural Alternatives International Inc. Common Stock (NAII)

Stock · NASDAQ · Health Care

$1.15as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

Natural Alternatives Reports Q4 Loss and Launches Strategic Review. Natural Alternatives International reported a wider quarterly loss driven by margin pressure, even as sales rose slightly year-over-year. The company announced it is conducting a comprehensive review to explore strategic alternatives and is consolidating its U.S. manufacturing operations into a single facility in Vista, California. These developments suggest a significant shift in the company's operational structure and future direction.

Active signals

Resistance level
$2.67
Industry
Medicinal Chemicals and Botanical Products

What NAII's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown25-4.3%24%
Bollinger Band Breakout20-9.4%30%
Volume Spike16-3.3%31%
200-Day Moving Average TouchActive now11-6.3%27%
Any 20-session window (baseline)-2.5%36%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About NAII

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutrition…

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
301

Fundamentals

1-day range
$1.1$1.19
Market cap
$14.94M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-3.42
Dividend yield
—
Beta
0.40
Avg. volume
41.9K
52-week range
$1.08$4.96
Next earnings: September 29, 2025confirmed

How Natural Alternatives International Inc. Common Stock Makes Money

Where the revenue actually goes — FY2026 annual results

market-wall.comTotalRevenue$142.51MCost of Revenue$133.52M (94%)Other$8.57M (6%)Tax$430.0K (0%)NAII

Source: 10-K filed Sep 28, 2026 · via SEC EDGAR / Finnhub

Gross Profit$9.00M(6%)
Operating Income-$18.75M(-13%)

Natural Alternatives International Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • NAII
    Natural Alternatives International Inc. Common Stock
    $1.15
    ▲ 2.68%
    Market cap $14.94MP/E —
    $1.08$4.96
  • MTEX
    Mannatech Incorporated Common Stock
    $7.13
    ▲ 0.00%
    Market cap $9.84MP/E —
    $3.8$12.45
  • BON
    Bon Natural Life Limited Class A Ordinary Shares
    $1.14
    ▲ 0.53%
    Market cap $8.86MP/E —
    $0.95$2.34
  • AKAN
    Akanda Corp. Common Shares
    $1.2
    ▼ 8.40%
    Market cap $2.90MP/E —
    $1.27$78.9
  • XXII
    22nd Century Group Inc. Common Stock
    $0.335
    ▼ 46.57%
    Market cap $2.23MP/E —
    $0.63411$540
  • IMCC
    IM Cannabis Corp. Common Shares
    $1.39
    ▲ 4.51%
    Market cap $768.0KP/E —
    $0.475$3.16
  • BTMD
    Biote Corp. Class A Common Stock
    $1.09
    ▼ 2.25%
    Market cap $61.26MP/E 6.81
    $1$3.26

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.